The pneumococcal testing market is projected to grow from USD 2.2 billion in 2025 to USD 6.4 billion by 2035, at a CAGR of 11.2%. Immunodiagnostics will dominate with a 43.6% market share, while consumables will lead the product segment with a 57.3% share.